A Publication for the Practising Medical Specialist, Industry Executive

Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. 

Stay Ahead in Medical Technology

At Medical Device News Magazine, we take pride in delivering high-quality, in-depth news. Our content goes beyond the surface, providing a comprehensive look at the trends, innovations, and breakthroughs that are shaping the future of medical technology.

In addition, we aim to offer a unique perspective on the rapidly evolving healthcare landscape. By following our news, you gain exclusive insights into industry developments, emerging technologies, and regulatory updates that impact medical devices worldwide. At the same time, you become part of a vibrant community of professionals, innovators, and thought leaders who are dedicated to advancing healthcare through cutting-edge solutions.

Furthermore, we encourage you to explore our diverse range of content, from the latest product announcements to in-depth analyses of industry trends. If our vision aligns with your objectives, we also offer opportunities for advertising and collaboration, allowing you to reach a highly engaged audience of medical technology professionals.

Stay informed, stay connected, and join us as we navigate the future of healthcare together.

Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook

Forma Medical Launches OptimalHT, the World’s First Minimally Invasive Instrumented Hammertoe Arthrodesis Procedure, Completes 50+ Procedures

“It’s no secret that minimally invasive surgery is the future of foot and ankle care,” said Dr. Noman Siddiqui, DPM, LifeBridge Health, Baltimore. “The novel OptimalHT approach for digital correction is ideal for less invasive surgery in the foot to reduce edema, expedite recovery, and achieve the results my patients demand.”

Clinical Trials

Magenta Medical

Magenta Medical Completes Enrollment to Early Feasibility Study for World’s Smallest Heart Pump

Magenta Medical notes All 15 study patients were enrolled and successfully treated at Mount Sinai Hospital, St. Francis Hospital and Heart Center, and North Shore University Hospital. The Elevate™ Early Feasibility Study was approved by the FDA to evaluate the safety and feasibility of the Elevate™ System in providing temporary mechanical circulatory support during HR-PCI procedures and constitutes the first step in a clinical program intended to secure approval for the device in the US for this indication.

Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial of BL-001, a Potential First-in-Class Therapeutic Being Developed for Both Dravet Syndrome and ALS

“Dravet syndrome is a rare and devastating form of childhood epilepsy in which there is an unmet need for patients whose seizures remain difficult to control and who experience significant side effects with current medications,” said Paolo Baroldi, PhD, MD, Chief Medical Officer of Bloom Science. “BL-001 shows promise as a novel treatment option that can change lives. With these results we plan to proceed into Phase 2 clinical development with doses we expect to be within the therapeutic window in both Dravet syndrome and ALS.”

New 24-Month Data Shows Nevro’s SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy

“The 24-month data from the SENZA-PDN RCT show us high-frequency SCS is a viable, long-term relief solution for people with PDN, which is particularly encouraging for a condition that naturally worsens over time,” said lead Principal Investigator Dr. Erika Petersen, Professor of Neurosurgery and Director of Functional and Restorative Neurosurgery at the University of Arkansas for Medical Sciences. “These results further validate not only the efficacy of high-frequency 10 kHz SCS for pain relief, but also show profound improvements in quality of life, sleep, and neurological function.”

Biotechnology News

Our Experts – Byline Articles

Read Their Views & Share With a Colleague or Two!

Proactively Building in Efficiency in Machine Translation Engines to Reduce Our Carbon Footprint

Proactively Building in Efficiency in Machine Translation Engines to Reduce Our Carbon Footprint

Dan Milczarski writes, “Recent estimates suggest that the carbon footprint of training a single AI is as much as 284 tons of carbon dioxide equivalent — five times the lifetime emissions of an average car. As a responsible global citizen, organizations and corporations should feel ethically compelled to do their part to improve our earth’s prognosis in this time of climate change.” Read on to learn more!

Executives on the Move

FDA Medical Device Updates

Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding

Market Reports

Advancements In Imaging

Hospitals In the News

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Non-Profit News

Healthcare: Understanding the Business Side of the Industry and Its Implications

Healthcare Careers

Nurses Corner

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.